PMDA drug package insert
テネリア錠20mg
PMDA Prescription drug · 田辺ファーマ株式会社 · package insert Dec 1, 2025
Key facts
| Brand names | テネリア錠20mg, テネリア錠40mg |
|---|---|
| Nonproprietary names | テネリグリプチン臭化水素酸塩水和物 |
| Companies | 製造販売元／田辺ファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 選択的DPP-4阻害剤-2型糖尿病治療剤- |
| Therapeutic category codes | 873969 |
| YJ codes | 3969015F1029, 3969015F2025 |
| Approval numbers | 22400AMX00728, 23000AMX00795 |
| Package insert edition | 第4版 |
| Package insert date | Dec 1, 2025 |
| PMDA document key | 400315_3969015F1029_2 |
| PMDA company code | 400315 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: